Subscriber Login   Users   Administrators
Online CE, compliance, and document control for clinical and histology laboratories

Sample Page

The page below is a sample from the MediaLab course, Hemolytic Disease of the Fetus and Newborn.

Learn about Compliance & CE courses available for clinical laboratories and individual medical technologists.

Advance Organizer

Before beginning the course take some time to review and think about what you already know about HDFN. For example, jot down brief notes to answer the following questions:

  1. Which antibody causes the most severe HDFN?
  2. Antibodies in which blood group system are the most common cause of positive direct antiglobulin tests (DATs) in newborns but rarely cause clinically significant hemolysis?
  3. Should DATs be performed on all newborns regardless of maternal ABO and Rh blood groups?
  4. What is Rh immune globulin (RhIg), its source, constituents, purpose, and mechanism of action?
  5. Which tests are used to determine postnatal RhIg dosage?
  6. Which type of D variant can produce anti-D?
  7. What follow-up tests are typically indicated if a pregnant female has a positive antibody screen when initially tested?
  8. Which laboratory findings would suggest that an infant may have ABO HDFN?
  9. How can the clinical status of fetuses at risk for HDFN be monitored?
  10. What are the characteristics of red cells suitable for intravenous transfusion to fetuses suffering from severe HDFN due to anti-D?








 

 

MediaLab, Inc.

http://www.MediaLabInc.net    |    (877) 776-8460 (tollfree)    |    sales@medialabinc.net